Loading...
Please wait, while we are loading the content...
Similar Documents
What you need to know about imaging the liver A practical review of current literature
| Content Provider | Semantic Scholar |
|---|---|
| Author | Bhattacharya, Gaurav Kabiri, Michael Callan, Laura |
| Copyright Year | 2014 |
| Abstract | Hepatic cancers are an increasing source of morbidity and mortality in the developing and the developed world. In this paper, we highlight the current imaging modalities used for various cystic and solid hepatic lesions. The rationale behind selection of these modalities and an efficient evidence‐based step‐by‐ step diagnostic algorithm are presented. Emphasis is placed on both identifying as well as differentiating between a benign, primary malignant and metastatic lesion. background Cancer of the liver remains one of the most common causes of cancer as well as cancer deaths worldwide1 and is responsible for about three quarters of a million deaths each year. While primarily concentrated in the developing world, the incidence is rising rapidly in developed countries. This includes Canada, where it has more than doubled over the last forty years.2 In North America, this ongoing rising incidence is due to increased prevalence of known underlying risk factors for liver cancer including the silent obesity‐related disease called non-alcoholic steatohepatitis (NASH), hepatitis B and C, cirrhosis, as well as an aging population now entering a period of disease manifestation. Patients will present to physicians in many different specialties due to the often non-specific or incidental presentations of this group of malignancies. Early identification is critical to improved outcome and health care providers in various specialties need to become knowledgeable of the recent advances in imaging, adjuvant therapies as well as stricter follow-up protocols in a multidisciplinary environment that lead to an earlier identification of metastases to the liver.3,4 The table5,6 highlights the potential differentials for malignant hepatic lesions which need to be identified and differentiated from their benign counterparts. Table: Malignant Hepatic Lesions CYSTIC Cystadenocarcinoma Squamous cell carcinoma Carcinoma of ovaries/pancreas/colon/kidneys |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.uwomj.com/wp-content/uploads/2014/10/v82no1_04.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
